Edwards Lifesciences Corp (NYSE:EW) shares, rose in value on Friday, April 26, with the stock price down by -1.30% to the previous day’s close as strong demand from buyers drove the stock to $86.87.
Actively observing the price movement in the recent trading, the stock is buoying the session at $88.01. The PE ratio was 37.74 over 12-month period. Referring to stock’s 52-week performance, its high was $96.12, and the low was $60.57. On the whole, EW has fluctuated by -8.70% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 6.52B, with a low estimate of 1.6B and a high estimate of 1.68B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.64B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EW’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 4.04, with the price of EW currently trading nearly -4.00% and -3.56% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.17, while the 7-day volatility ratio is showing 1.83% which for the 30-day chart, stands at 2.17%. Furthermore, Edwards Lifesciences Corp (EW)’s beta value is 1.08, and its average true range (ATR) is 2.12.
A comparison of Edwards Lifesciences Corp (EW) with its peers suggests the former has fared considerably weaker in the market. EW showed an intraday change of -1.30% in today’s session so far, and over the past year, it shrunk by -0.62%%.
Data on historical trading for Edwards Lifesciences Corp (NYSE:EW) indicates that the trading volumes over the past 3 months, they’ve averaged 3.99 million. According to company’s latest data on outstanding shares, there are 601.10 million shares outstanding.
Nearly 1.58% of Edwards Lifesciences Corp’s shares belong to company insiders and institutional investors own 82.27% of the company’s shares. The stock has risen by 13.92% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EW stock heading into the next quarter.
